Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal health

ISIN: US14149Y1082 , WKN: 880206

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company\'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company\'s Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind

2025-04-14
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.

Q4 Earnings Outperformers: Patterson Companies (NASDAQ:PDCO) And The Rest Of The Healthcare Distribution & Related Services Stocks

2025-04-14
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at healthcare distribution & related services stocks, starting with Patterson Companies (NASDAQ:PDCO).

Those who invested in Cardinal Health (NYSE:CAH) five years ago are up 196%

2025-04-13
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Dividend Champion, Contender, And Challenger Highlights: Week Of April 13

2025-04-12
Read here for highlights on recent and upcoming dividend related activity for dividend stocks on the Dividend Champions list.

Here's Why Cardinal Health (CAH) is a Strong Value Stock

2025-04-11
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DGX Stock Gains Following the Launch of New AD-Detect Blood Test

2025-04-11
Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.

Cardinal Health (CAH) Stock Moves -1.2%: What You Should Know

2025-04-10
The latest trading day saw Cardinal Health (CAH) settling at $128.88, representing a -1.2% change from its previous close.

ESG Still Matters. 3 Defensive Stocks That Make the Grade.

2025-04-10
ESG Still Matters. 3 Defensive Stocks That Make the Grade.

Align Technology (ALGN) Moves 14.4% Higher: Will This Strength Last?

2025-04-10
Align Technology (ALGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cardinal Health (NYSE:CAH) Selected By Telix For U.S. Launch Of Gozellix Imaging Agent

2025-04-09
Cardinal Health (NYSE:CAH) has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development for the company, particularly in the U.S. market. Over the last quarter, Cardinal Health's stock moved 2%, a performance slightly better than the broader market's decline amid market volatility and tariff concerns. The company's partnership with Telix, combined with strategic board appointments of healthcare and tech experts, might have offered some resilience against...